Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Shirihai Orian"

From Bioblast
(5 intermediate revisions by 2 users not shown)
Line 3: Line 3:
|lastname=Shirihai
|lastname=Shirihai
|firstname=Orian
|firstname=Orian
|title=Dr.
|title=MD, PhD, Professor, Molecular and Medical Pharmacology


|institution=Boston University School of Medicine
|institution=
[[File:Shirihai_O.jpg|right|150px]]
[[File:Shirihai_O.jpg|right|150px]]
Department of Medicine
Dept. Molecular and Medical Pharmacology
|address=650 Albany St.
 
|area code=02118
33-131E Center for Health Sciences
|city=Boston
 
|state=Massachusetts (MA)
University of California, Los Angeles, UCLA
|address=10833 Le Conte Ave
|area code=90095
|city=Los Angeles
|state=California (CA)
|country=USA
|country=USA
|mailaddress=OShirihai@mednet.ucla.edu
|mailaddress=OShirihai@mednet.ucla.edu
}}
}}
{{Labelingperson}}


==Participated at==
==Participated at==
::::* [[MiPNet28.03 IOC157 Los Angeles US |2023 O2k-Workshop UCLA]]
::::* [[MiP2014| MiP2014 Obergurgl AT]]
::::* [[MiP2014| MiP2014 Obergurgl AT]]
{{Labelingperson}}

Revision as of 17:49, 16 February 2023


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Shirihai Orian


Name Shirihai Orian, MD, PhD, Professor, Molecular and Medical Pharmacology
Institution
Shirihai O.jpg

Dept. Molecular and Medical Pharmacology

33-131E Center for Health Sciences

University of California, Los Angeles, UCLA

Address 10833 Le Conte Ave, 90095
City Los Angeles
State/Province California (CA)
Country USA
Email OShirihai@mednet.ucla.edu
Weblink
O2k-Network Lab US CA Los Angeles Shirihai O


Participated at


Labels:



Publications

 PublishedReference
Rodriguez-Nuevo 2018 EMBO J2018Rodríguez-Nuevo A, Díaz-Ramos A, Noguera E, Díaz-Sáez F, Duran X, Muñoz JP, Romero M, Plana N, Sebastián D, Tezze C, Romanello V, Ribas F, Seco J, Planet E, Doctrow SR, González J, Borràs M, Liesa M, Palacín M, Vendrell J, Villarroya F, Sandri M, Shirihai O, Zorzano A (2018) Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. EMBO J 37.

Abstracts

 PublishedReference
Shirihai 2023 MiP20232023
Shirihai Orian
Inhibition of ATP synthase hydrolytic activity restores cellular energy homeostasis in conditions of impaired respiration.
Cerqueira 2016 Abstract Mito Xmas Meeting Innsbruck2016The Deubiquitinating (DUB) protein Ubiquitin carboxyl- terminal hydrolase L1 (UCH-L1) regulates Mitofusin-2 levels and  mitochondrial function in mammalian cell lines and in D. Melanogaster.
Shirihai 2014 Abstract MiP20142014Mitochondrial dynamics and quality control, a conflict of interest.
Trudeau 2014 Abstract MiP20142014Role of mitochondrial fusion and motility in distributing young mitochondrial protein and removing old protein from the mitochondrial network.